Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro
Herpes simplex virus type 1 (HSV-1) infections are one of the most common diseases in human population. HSV-1 causes subclinical, mild to severe diseases, especially in immunocompromised patients. Acyclovir has been used to reduce manifestations of HSV-1 infections. The extensive use of this drug ha...
Main Authors: | Mehdi Shabani, Bahram Nasr Esfahani, Bahar Sadegh Ehdaei, Sharareh Moghim, Arezoo Mirzaei, Mohammadreza Sharifi, Leili Mouhebat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2019;volume=14;issue=2;spage=167;epage=174;aulast=Shabani |
Similar Items
-
In-Vitro Evaluation of miR-101-5P Effect on Herpes Simplex Virus Replication
by: Ahmad Piroozmand, et al.
Published: (2018-11-01) -
Changes of MicroRNA Expression and Apoptosis in Endometrial Glandular Epithelial Cells under Hypoxic
by: WANG Hanbi, et al.
Published: (2022-07-01) -
Modulation of experimental acute lung injury by exosomal miR-7704 from mesenchymal stromal cells acts through M2 macrophage polarization
by: Wei-Ting Lin, et al.
Published: (2024-03-01) -
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
by: Christiane Silke Heilingloh, et al.
Published: (2020-08-01) -
Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1
by: Jinling Zhou, et al.
Published: (2022-04-01)